Gregory K. Behbehani

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Decrease post-transplant relapse using donor-derived expanded NK-cells”.

Decrease post-transplant relapse using donor-derived expanded NK-cells

Leukemia(2021)10.1038/s41375-021-01349-4

N/A

2.5DataRank · unranked

104 citations

Piyanuch Kongtim, Doris Soebbing, Prashant Trikha, Gregory K. Behbehani, Gabriela Rondón +15 more

Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors

JCI Insight(2024)10.1172/jci.insight.169927

N/A

0.312DataRank · unranked

6 citations

Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good, Steven Sun +27 more

Alternative methods of viability determination in single cell mass cytometry

Cytometry Part A(2021)10.1002/cyto.a.24308

N/A

0DataRank · unranked

9 citations

Hussam Alkhalaileh, Justin Lyberger, Gregory K. Behbehani, Raymond D. Devine

CRISPR-Targeted CAR Gene Insertion Using Cas9/RNP and AAV6 Enhances Anti-AML Activity of Primary NK Cells

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.17.435886

N/A

0DataRank · unranked

15 citations

Shibi Likhite, Ezgi Elmas, Kenta Yamamoto, M. Schwartz, Kinnari Sorathia +9 more

Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV

Cell Reports Methods(2022)10.1016/j.crmeth.2022.100236

N/A

0DataRank · unranked

57 citations

Shibi Likhite, Ezgi Elmas, Kenta Yamamoto, M. Schwartz, Kinnari Sorathia +10 more

Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein–Barr Virus Lymphoproliferative Disorder

Cancers(2023)10.3390/cancers15113046

N/A

0DataRank · unranked

9 citations

Mark Lustberg, Claire Hale, Shelby Sloan, Charlene Mao, Xiaoli Zhang +18 more

Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200820

N/A

0DataRank · unranked

5 citations

Gaurav Nayyar, Meijuan Tian, Dean A. Lee, M. Fevzi Özkaynak, Jessica Ayala-Cuesta +11 more

PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease

JCI Insight(2020)10.1172/jci.insight.131099

N/A

0DataRank · unranked

37 citations

Nina C. Zitzer, Yandi Gao, Hannah Choe, Natalie E. Sell, Lotus Neidemire-Colley +15 more

BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics in vivo

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200808

N/A

0DataRank · unranked

4 citations

Matthew Nazzaro, Mykyta Artomov, Lakshmi P. Rao Venkata, Diana Thomas, Justin Lyberger +8 more

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation

Cytometry Part B Clinical Cytometry(2020)10.1002/cyto.b.21860

N/A

0DataRank · unranked

35 citations

Rachel Finck, Nikolay Samusik, Kunju Sridhar, Wendy J. Fantl, Peter L. Greenberg +2 more